Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse
Open Access
- 4 April 2026
- journal article
- review article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
Dormant cancer stem cells (CSCs) are the root cause of the drug resistance and metastatic processes of malignant tumors, but an in-depth analysis of their biological mechanisms is needed. Dormant CSCs are in the G0 phase of the cell cycle and are characterized by enhanced autophagic activity, a stable genomic structure and strong plasticity. Recently, several new specific markers of dormant CSCs, such as p27, CD13, QSOX1, Survivin, GPD1 and BEX2, have been identified, which offer hope for targeted therapy. In addition, epigenetic modifications such as DNA methylation and histone modifications have been reported to regulate the transition between the quiescent and proliferative states of dormant CSCs. From a clinical perspective, keeping cancer stem cells in a dormant state is helpful for preventing tumor recurrence and metastasis. To this end, clarifying the potential mechanisms and molecular regulation of cancer stem cell dormancy is vital. Here, in this review, we examine recent significant findings regarding tumor stem cell dormancy in both experimental and human disease models, emphasizing the underlying molecular mechanisms, regulatory processes, experimental models, and prospective research directions aimed at advancing this field and enhancing clinical translation.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2025A1515012583)
This publication has 198 references indexed in Scilit:
- Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 PatientsJournal of Surgical Oncology, 2025
- A Live Tracker of Dormant Disseminated Tumor Cells2024
- Are 90% of deaths from cancer caused by metastases?Cancer Medicine, 2019
- The histone chaperone complex FACT promotes proliferative switch of G0 cancer cellsInternational Journal of Cancer, 2018
- Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaJAMA Oncology, 2017
- Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic HypoxiaJournal of Cellular Biochemistry, 2017
- Epithelial–mesenchymal transition in tumor metastasisMolecular Oncology, 2016
- A method for evaluating the use of fluorescent dyes to track proliferation in cell lines by dye dilutionCytometry Part A, 2013
- Effective Elimination of Cancer Stem Cells By a Novel Drug Combination StrategyStem Cells, 2012
- Cancer Stem Cells and Tumor Dormancy2012